Dentzer James E 4

What Happened
James E. Dentzer, a director of Imunon, Inc. (IMNN), received an award of 11,148 shares on 2026-05-22. The grant is reported at $2.20 per share for a total value of $24,526 and was issued in lieu of a portion of his board fees (transaction code A — award/grant). This was a compensation-related acquisition (not an open-market purchase).

Key Details

• Transaction date: 2026-05-22; Filing date: 2026-05-27.
• Transaction type/code: Award/Grant (A).
• Shares acquired: 11,148 at $2.20 per share; total reported value $24,526.
• Footnote: F1 — stock granted in lieu of cash for a portion of board fees.
• Stock dividend note: Issuer paid a 15% stock dividend on 2025-08-21 (record date 2025-08-07); share amounts were adjusted accordingly.
• Shares owned after transaction: Not specified in the filing.
• Timeliness: Filed five days after the transaction (later than the SEC’s typical 2-business-day Form 4 filing requirement).

Context
This is a routine director compensation award rather than a market purchase or sale; such grants compensate service and do not necessarily signal the director’s market view. The filing includes an adjustment note reflecting a prior 15% stock dividend, which affects reported share counts.